HOME › DRUGS › COVID-19 VACCINE (AD26.COV2-S [RECOMBINANT])
ACTIVE SUBSTANCE / INN

COVID-19 VACCINE (AD26.COV2-S [RECOMBINANT])

Brand name(s): Jcovden (previously COVID-19 Vaccine Janssen)
EMA LISTED
WITHDRAWN
COVID-19 virus infection
ACTIVE SUBSTANCE
Covid-19 Vaccine (Ad26.Cov2-S [Recombinant])
REGULATORS
EMA
SPONSORS / MAH
Janssen-Cilag International NV
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Jcovden (previously COVID-19 Vaccine Janssen)Janssen-Cilag International NVWithdrawn11/03/2021COVID-19 virus infection

FULL INTELLIGENCE ON COVID-19 VACCINE (AD26.COV2-S [RECOMBINANT])

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →